Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicity Testing Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Cell Culture Technologies
1.2.3 High-throughput Technologies
1.2.4 Toxicogenomics
1.3 Market by Application
1.3.1 Global In-Vitro Toxicity Testing Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Pharmaceuticals & Biopharmaceuticals
1.3.3 Cosmetic & Household Products
1.3.4 Food
1.3.5 Chemicals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Toxicity Testing Market Perspective (2018-2034)
2.2 In-Vitro Toxicity Testing Growth Trends by Region
2.2.1 Global In-Vitro Toxicity Testing Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 In-Vitro Toxicity Testing Historic Market Size by Region (2018-2023)
2.2.3 In-Vitro Toxicity Testing Forecasted Market Size by Region (2024-2034)
2.3 In-Vitro Toxicity Testing Market Dynamics
2.3.1 In-Vitro Toxicity Testing Industry Trends
2.3.2 In-Vitro Toxicity Testing Market Drivers
2.3.3 In-Vitro Toxicity Testing Market Challenges
2.3.4 In-Vitro Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Toxicity Testing Players by Revenue
3.1.1 Global Top In-Vitro Toxicity Testing Players by Revenue (2018-2023)
3.1.2 Global In-Vitro Toxicity Testing Revenue Market Share by Players (2018-2023)
3.2 Global In-Vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Toxicity Testing Revenue
3.4 Global In-Vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicity Testing Revenue in 2024
3.5 In-Vitro Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-Vitro Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-Vitro Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicity Testing Historic Market Size by Type (2018-2023)
4.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2024-2034)
5 In-Vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicity Testing Historic Market Size by Application (2018-2023)
5.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America In-Vitro Toxicity Testing Market Size (2018-2034)
6.2 North America In-Vitro Toxicity Testing Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America In-Vitro Toxicity Testing Market Size by Country (2018-2023)
6.4 North America In-Vitro Toxicity Testing Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Toxicity Testing Market Size (2018-2034)
7.2 Europe In-Vitro Toxicity Testing Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe In-Vitro Toxicity Testing Market Size by Country (2018-2023)
7.4 Europe In-Vitro Toxicity Testing Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicity Testing Market Size (2018-2034)
8.2 Asia-Pacific In-Vitro Toxicity Testing Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Toxicity Testing Market Size (2018-2034)
9.2 Latin America In-Vitro Toxicity Testing Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America In-Vitro Toxicity Testing Market Size by Country (2018-2023)
9.4 Latin America In-Vitro Toxicity Testing Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicity Testing Market Size (2018-2034)
10.2 Middle East & Africa In-Vitro Toxicity Testing Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Covance
11.2.1 Covance Company Detail
11.2.2 Covance Business Overview
11.2.3 Covance In-Vitro Toxicity Testing Introduction
11.2.4 Covance Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.2.5 Covance Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare In-Vitro Toxicity Testing Introduction
11.4.4 GE Healthcare Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.4.5 GE Healthcare Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific In-Vitro Toxicity Testing Introduction
11.5.4 Eurofins Scientific Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.5.5 Eurofins Scientific Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA In-Vitro Toxicity Testing Introduction
11.6.4 Merck KGaA Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Detail
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories In-Vitro Toxicity Testing Introduction
11.7.4 Charles River Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.7.5 Charles River Laboratories Recent Development
11.8 Catalent
11.8.1 Catalent Company Detail
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicity Testing Introduction
11.8.4 Catalent Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.8.5 Catalent Recent Development
11.9 Cyprotex
11.9.1 Cyprotex Company Detail
11.9.2 Cyprotex Business Overview
11.9.3 Cyprotex In-Vitro Toxicity Testing Introduction
11.9.4 Cyprotex Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.9.5 Cyprotex Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN In-Vitro Toxicity Testing Introduction
11.10.4 QIAGEN Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.10.5 QIAGEN Recent Development
11.11 Promega
11.11.1 Promega Company Detail
11.11.2 Promega Business Overview
11.11.3 Promega In-Vitro Toxicity Testing Introduction
11.11.4 Promega Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.11.5 Promega Recent Development
11.12 Gentronix
11.12.1 Gentronix Company Detail
11.12.2 Gentronix Business Overview
11.12.3 Gentronix In-Vitro Toxicity Testing Introduction
11.12.4 Gentronix Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.12.5 Gentronix Recent Development
11.13 BioIVT
11.13.1 BioIVT Company Detail
11.13.2 BioIVT Business Overview
11.13.3 BioIVT In-Vitro Toxicity Testing Introduction
11.13.4 BioIVT Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.13.5 BioIVT Recent Development
11.14 MB Research Laboratories
11.14.1 MB Research Laboratories Company Detail
11.14.2 MB Research Laboratories Business Overview
11.14.3 MB Research Laboratories In-Vitro Toxicity Testing Introduction
11.14.4 MB Research Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023)
11.14.5 MB Research Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Cell Culture Technologies
Table 3. Key Players of High-throughput Technologies
Table 4. Key Players of Toxicogenomics
Table 5. Global In-Vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global In-Vitro Toxicity Testing Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global In-Vitro Toxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global In-Vitro Toxicity Testing Market Share by Region (2018-2023)
Table 9. Global In-Vitro Toxicity Testing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global In-Vitro Toxicity Testing Market Share by Region (2024-2034)
Table 11. In-Vitro Toxicity Testing Market Trends
Table 12. In-Vitro Toxicity Testing Market Drivers
Table 13. In-Vitro Toxicity Testing Market Challenges
Table 14. In-Vitro Toxicity Testing Market Restraints
Table 15. Global In-Vitro Toxicity Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global In-Vitro Toxicity Testing Market Share by Players (2018-2023)
Table 17. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2024)
Table 18. Ranking of Global Top In-Vitro Toxicity Testing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by In-Vitro Toxicity Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players In-Vitro Toxicity Testing Product Solution and Service
Table 22. Date of Enter into In-Vitro Toxicity Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In-Vitro Toxicity Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2023)
Table 26. Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2024-2034)
Table 28. Global In-Vitro Toxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2023)
Table 30. Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2024-2034)
Table 32. North America In-Vitro Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America In-Vitro Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America In-Vitro Toxicity Testing Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe In-Vitro Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe In-Vitro Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe In-Vitro Toxicity Testing Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific In-Vitro Toxicity Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America In-Vitro Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America In-Vitro Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America In-Vitro Toxicity Testing Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa In-Vitro Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2024-2034) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific In-Vitro Toxicity Testing Product
Table 50. Thermo Fisher Scientific Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Covance Company Detail
Table 53. Covance Business Overview
Table 54. Covance In-Vitro Toxicity Testing Product
Table 55. Covance Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 56. Covance Recent Development
Table 57. Bio-Rad Laboratories Company Detail
Table 58. Bio-Rad Laboratories Business Overview
Table 59. Bio-Rad Laboratories In-Vitro Toxicity Testing Product
Table 60. Bio-Rad Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 61. Bio-Rad Laboratories Recent Development
Table 62. GE Healthcare Company Detail
Table 63. GE Healthcare Business Overview
Table 64. GE Healthcare In-Vitro Toxicity Testing Product
Table 65. GE Healthcare Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 66. GE Healthcare Recent Development
Table 67. Eurofins Scientific Company Detail
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific In-Vitro Toxicity Testing Product
Table 70. Eurofins Scientific Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Merck KGaA Company Detail
Table 73. Merck KGaA Business Overview
Table 74. Merck KGaA In-Vitro Toxicity Testing Product
Table 75. Merck KGaA Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 76. Merck KGaA Recent Development
Table 77. Charles River Laboratories Company Detail
Table 78. Charles River Laboratories Business Overview
Table 79. Charles River Laboratories In-Vitro Toxicity Testing Product
Table 80. Charles River Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 81. Charles River Laboratories Recent Development
Table 82. Catalent Company Detail
Table 83. Catalent Business Overview
Table 84. Catalent In-Vitro Toxicity Testing Product
Table 85. Catalent Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 86. Catalent Recent Development
Table 87. Cyprotex Company Detail
Table 88. Cyprotex Business Overview
Table 89. Cyprotex In-Vitro Toxicity Testing Product
Table 90. Cyprotex Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 91. Cyprotex Recent Development
Table 92. QIAGEN Company Detail
Table 93. QIAGEN Business Overview
Table 94. QIAGEN In-Vitro Toxicity Testing Product
Table 95. QIAGEN Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 96. QIAGEN Recent Development
Table 97. Promega Company Detail
Table 98. Promega Business Overview
Table 99. Promega In-Vitro Toxicity Testing Product
Table 100. Promega Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 101. Promega Recent Development
Table 102. Gentronix Company Detail
Table 103. Gentronix Business Overview
Table 104. Gentronix In-Vitro Toxicity Testing Product
Table 105. Gentronix Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 106. Gentronix Recent Development
Table 107. BioIVT Company Detail
Table 108. BioIVT Business Overview
Table 109. BioIVT In-Vitro Toxicity Testing Product
Table 110. BioIVT Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 111. BioIVT Recent Development
Table 112. MB Research Laboratories Company Detail
Table 113. MB Research Laboratories Business Overview
Table 114. MB Research Laboratories In-Vitro Toxicity Testing Product
Table 115. MB Research Laboratories Revenue in In-Vitro Toxicity Testing Business (2018-2023) & (US$ Million)
Table 116. MB Research Laboratories Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Toxicity Testing Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global In-Vitro Toxicity Testing Market Share by Type: 2024 VS 2034
Figure 3. Cell Culture Technologies Features
Figure 4. High-throughput Technologies Features
Figure 5. Toxicogenomics Features
Figure 6. Global In-Vitro Toxicity Testing Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global In-Vitro Toxicity Testing Market Share by Application: 2024 VS 2034
Figure 8. Pharmaceuticals & Biopharmaceuticals Case Studies
Figure 9. Cosmetic & Household Products Case Studies
Figure 10. Food Case Studies
Figure 11. Chemicals Case Studies
Figure 12. In-Vitro Toxicity Testing Report Years Considered
Figure 13. Global In-Vitro Toxicity Testing Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global In-Vitro Toxicity Testing Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global In-Vitro Toxicity Testing Market Share by Region: 2024 VS 2034
Figure 16. Global In-Vitro Toxicity Testing Market Share by Players in 2024
Figure 17. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by In-Vitro Toxicity Testing Revenue in 2024
Figure 19. North America In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America In-Vitro Toxicity Testing Market Share by Country (2018-2034)
Figure 21. United States In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe In-Vitro Toxicity Testing Market Share by Country (2018-2034)
Figure 25. Germany In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific In-Vitro Toxicity Testing Market Share by Region (2018-2034)
Figure 33. China In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America In-Vitro Toxicity Testing Market Share by Country (2018-2034)
Figure 41. Mexico In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa In-Vitro Toxicity Testing Market Share by Country (2018-2034)
Figure 45. Turkey In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia In-Vitro Toxicity Testing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 48. Covance Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 50. GE Healthcare Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 51. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 52. Merck KGaA Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 53. Charles River Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 54. Catalent Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 55. Cyprotex Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 56. QIAGEN Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 57. Promega Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 58. Gentronix Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 59. BioIVT Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 60. MB Research Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed